|
TMEM87B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.652000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.591000E-01 |
| Normal-vs-Stage2 |
9.280000E-01 |
| Normal-vs-Stage3 |
5.871200E-01 |
| Normal-vs-Stage4 |
5.223800E-01 |
| Stage1-vs-Stage2 |
6.082000E-01 |
| Stage1-vs-Stage3 |
1.327190E-01 |
| Stage1-vs-Stage4 |
1.440960E-01 |
| Stage2-vs-Stage3 |
5.292200E-01 |
| Stage2-vs-Stage4 |
4.553200E-01 |
| Stage3-vs-Stage4 |
8.477400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.433400E-01 |
| Normal-vs-AfricanAmerican |
1.866610E-01 |
| Normal-vs-Asian |
4.439600E-01 |
| Caucasian-vs-AfricanAmerican |
4.628700E-04 |
| Caucasian-vs-Asian |
2.172600E-01 |
| AfricanAmerican-vs-Asian |
4.935700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.085400E-01 |
| Normal-vs-Female |
9.755200E-01 |
| Male-vs-Female |
5.880800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.506600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.836200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.643800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.938600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.443400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.149400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.645200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.915800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.926100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.380300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.576000E-01 |
| Normal-vs-Grade 2 |
7.497400E-01 |
| Normal-vs-Grade 3 |
7.649600E-01 |
| Normal-vs-Grade 4 |
2.524000E-01 |
| Grade 1-vs-Grade 2 |
7.303200E-03 |
| Grade 1-vs-Grade 3 |
7.732300E-02 |
| Grade 1-vs-Grade 4 |
1.416770E-03 |
| Grade 2-vs-Grade 3 |
1.047240E-01 |
| Grade 2-vs-Grade 4 |
1.203200E-01 |
| Grade 3-vs-Grade 4 |
1.709880E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.280200E-01 |
| Normal-vs-ccB subtype |
2.055800E-01 |
| ccA subtype-vs-ccB subtype |
2.392100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.987400E-01 |
| Normal-vs-N1 |
3.755600E-01 |
| N0-vs-N1 |
2.470400E-01 |
|
|
